Angiotensin-converting enzyme inhibition in type I diabetic nephropathy

Contributions to Nephrology

Volumn 118, Issue , 1996, Pages 206-213

  Lewis, Edmund J ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL; BLOOD PRESSURE; DIABETIC NEPHROPATHY; DRUG EFFECT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HUMANS; PROTEINURIA;

EID: 0029689676     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (4)

1. Keane WF, Anderson S, Aurell M, de Zeeuw D, Narins RG, Povar G: Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Ann Intern Med 1989;111:503-516.
2. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition of diabetic nephropathy. N Engl J Med 1989;329:1456-1462.
3. Viberti G, Mogensen CE, Groop LC, Pauls JF, for the European Microalbuminuria Captopril Study Group: JAMA 1994;271:275-279.
4. Mathiesen EF, Hommel E, Giese J, Parving H-H: Efficacy of captopril in postponing nephropathy in normotensive insulin-dependent diabetic patients with microalbuminuria. BMJ 1991;303:81-87.